This web only provides the extract of this article. If you want to read the figures and tables, please reference the PDF full text on Blackwell Synergy. Thank you.
- Original Article -
Biophysical mechanism-mediated time-dependent effect on
sperm of human and monkey vas implanted polyelectrolyte contraceptive
Sujoy K. Guha
School of Medical Science and Technology, Indian Institute of Technology and National Institute of Medical Science
and Technology, Kharagpur 721302, India
Abstract
Aim: To determine the short and long-term morphological effects on sperm as induced by intra-vas alteration of pH
and electrical charge. Methods: Desired biophysical influences were obtained by injection of reversible inhibition of
sperm under guidance (RISUG) into the lumen of the vas deferens of human subjects and the monkey. RISUG is a
polyelectrolyte hydrogel complex of styrene maleic anhydride (SMA) and dimethyl sulfoxide (DMSO) which
generates an electrostatic charge and also lowers in a near space of pH domain. The morphology of sperm was examined by
light microscopy, scanning and transmission electron microscopy. Human study enabled semen collection by
masturbation as early as 3 h after injection and studies extended up to 6 months. In the monkey, on vas excision after
RISUG implantation, sperm characteristics were examined in serial sections.
Results: Semenology in clinical studies and histological data of the monkey showed a time-sequenced sperm plasma membrane, tail mitochondria and nuclear
decondensation alterations in sperm structural components, which beared marked similarity to changes in the sperm
head and tail during capacitation and entry into the
ovum. Conclusion: The findings provide a means of causing such
changes in the sperm that inhibit the fertilizing ability before the nucleus is affected. Therefore achieving
non-obstructive vas-based contraception, without genotoxic or teratogenic effects caused by infertile sperm passing into the
semen, is feasible. (Asian J Androl 2007 Mar; 9: 221_227)
Keywords: reversible inhibition of sperm under guidance; vas deferens; electrical charge; sperm; electron microscopy; acrosome; mitochondria;
chromatin decondensation
Correspondence to: Prof. Sujoy K. Guha, School of Medical Science and Technology, Indian Institute of Technology, Kharagpur 721302,
India.
Tel: +91-3222-283574 Fax: +91-3222-262221
E-mail: guha_sk@yahoo.com
Received 2006-01-07 Accepted 2006-08-20
DOI: 10.1111/j.1745-7262.2007.00244.x
1 Introduction
Sperm morphology and function are known to be affected with systemic administration of chemical agents,
but effects following injection into the vas deferens
remain undefined. Limited available data pertains to a
reduction in sperm count brought about by the blocking
action of passive lumen occluding agents such as
silicone rubber and polyurethane. Consequences of
partially occluding intra-vas bioactive compounds require
further investigation for insight into long-term close
interaction of a motile gamete with a bioactive foreign body.
In vitro preparations are not sustainable because of sperm
protein denaturation and bacterial growth and, hence, do
not provide the necessary information. With polyelectrolytic intra-vas bioactive compound, a very special
condition prevails. The motile sperm, possessing a
negative electrical surface charge, is exposed to the electrical
charge and acidifying pH of the polyelectrolyte. A
consistent result will have a bearing on fertility control and
possibly on infertility management.
The polyelectrolyte styrene maleic anhydride (SMA)
complexed with dimethyl sulfoxide (DMSO), given the
name `reversible inhibition of sperm under guidance'
(RISUG), was selected on account of its electrical charge
and pH lowering action on hydration and biocompatibility.
Earlier studies have shown that over a period of 72 h
after injection three changes occur. First, the drug forms
a precipitate inside the lumen, which appears as flakes
seen under scanning electron microscopy [1]. The flaky
character of the precipitate forms a maze of passages
along which sperms can pass brushing the flakes. Second, the precipitate develops a surface electrical
charge. Microelectrophoresis shows that small
aggregates of hydrated RISUG have different electrical charges.
There is a surface mosaic of positive and negative charges
with the positive dominating. Concurrently the pH in
the vicinity of the precipitate falls. Hence, the sperms
passing along the passages in between the precipitate
flakes are subjected to an electrical charge stress and
pH stress. Third, the vas peristalsis propels some of
the precipitate along the vas lumen towards the
ejaculatory duct end. In time the precipitate swells by
interaction with water molecules in the vas lumen.
Micro-projections of the flakes are formed and these
invaginate into the vas mucosal folds thereby helping to
provide a retentive force against evacuation by vas
deferens peristalsis. Thus, a stable bioactive implant is formed
along a length of the vas deferens, which may extend
beyond the internal inguinal ring. In this manner, RISUG
transforms from a drug without intrinsic electrical
charge into a medical device a stable implant that
has an electrical charge.
DMSO is strongly alkaline and hygroscopic. A part
of the styrene maleic anhydride is inevitably converted
to styrene maleic acid, which considerably neutralizes
the alkaline pH of DMSO. This action reduces the tissue
reactivity of DMSO. However, because the sulphur moiety of DMSO is highly reactive it interacts with the
etheric oxygen (O) of SMA, thereby forming an SMA-DMSO complex and dimethyl maleic anhydride.
Positively charged amino groups of intra-vas fluid proteins
are replaced by negative carboxyl groups resulting in an
increase in the negative charges per amino group.
Depending on the steric conformation of the SMADMSOamino acid complexes, a mosaic of
positive and negative charge domains occur and subject
moving sperm to charge oscillations. The charge
oscillations occur because morphological deformations
during sperm movement lead to alterations in the domain
spacing, which is alternating [2]. Polyelectrolytes by
their charge interactions can affect enzymesubstrate
distribution and reaction rates [3] and create domains in
lipid bilayer membranes [4]. Sperms have a very
distinctive lipid composition and alterations in the lipid
structures are an integral part of the capacitation process prior
to fertilization. The SMADMSOamino acid complex probably affects sperm surface enzymes and lipid
domains thereby increasing membrane fluidity and
destabilizing sperm membranes. This happens in spite of the
luminal pH being rendered acidic by the RISUG, a
condition known to stabilize sperms [5]. Membrane
breakdown produces acrosomal enzyme acrosin and
hyaluronidase release and loss of fertilizing ability.
Safety, contraceptive efficacy and reversibility of a
single intra-vas injection of SMADMSO combination has
been assessed in animal models [6] and clinical studies
[7]. The present report draws, in part, upon data
obtained from clinical trial subjects of investigations that
were not a part of this clinical trial.
2 Materials and methods
The present analysis draws upon information from
studies on volunteer men and monkeys. The reasons
behind considering humans and monkeys are:
1. Effects on spermatozoa soon after intra-vas
injection of RISUG cannot be obtained from the monkey study
because electro-ejaculation of the monkey to collect
semen a short time after injection, which is done under
general anesthesia, is not possible. Even after recovery from
the anesthesia monkeys in our laboratory take several
days to respond to electro-ejaculation attempts. In contrast,
men who are injected under a local scrotal anesthesia
have no difficulty in giving semen sample by
masturbation 3 h after the injection.
2. Data on changes in the spermatozoa during transit in
the vas deferens cannot be obtained in the human because
medical ethics does not permit taking out an entire
length of the vas deferens in the human for experimental studies
which is a procedure that could be done on the monkey.
3. The low dose administration effects and effects
after 6 months could have been obtained both in the
human and the monkey. Here the human data has been
considered because in the human semen samples can be
obtained with regularity whereas the rhesus monkeys in
our studies cannot be ejaculated in the summer months.
2.1 Humans
Group I consisted of three subjects and semen was
collected 3 h after RISUG injection. Group II consisted
of six subjects who were administered a sub-therapeutic
dose of 80 µL of RISUG into each vas deferens.
Borderline fertility control is manifested but there were
spermatozoa present in the ejaculate. Semen samples by
masturbation were taken serially beginning 14 days or
more after injection. Samples were considered for the
analysis 3 months after the injection. Group III
consisted of 12 subjects. These subjects were the
volunteers in Phase II and Phase III clinical trials, who were
administered the standard therapeutic dose of 120 µL of
RISUG into each vas deferens. Semen samples by
masturbation were taken serially beginning 14 days or more
after injection.
All male volunteers were adults of age < 40 years, in
good health and had `proven fertility', with at least two
living children, and had no history of having failed to
induce conception despite unprotected intercourse over
a period of 6 months. Prior to the RISUG injection, at
least one semen sample was obtained by masturbation,
with no specific period of abstinence, had good semen
quality with: (1) count of > 20 million/mL, (2) > 50%
spermatozoa having normal morphology; and (3) > 50%
motile spermatozoa.
Semen was collected on masturbation and processed
according to WHO Guidelines. Sperms were examined
under light microscopy (LM) after HE staining,
scanning electron microscopy (SEM) and transmission
electron microscopy (TEM). In Group II subjects, who had
intact sperms seen by a Triple Stain Technique (TST)
[8], the acrosome reaction was determined. For TST
the sperm cells were first stained with 1% Trypan blue
and then smeared and fixed (3% glutaraldehyde) on a
glass slide. The cells were then stained with 0.8% Bismark
brown and 0.8% Rose Bengal at 40ºC and 24ºC
respectively. After mounting the slides were examined
with light microscopy.
2.2 Monkeys
Group I consisted of one adult (proven fertile) rhesus
monkey with bodyweight above 7 kg. The entire length
of the vas deferens was taken surgically from the scrotal
segment to the ampulla exposed bilaterally. On one side
knots were placed around the vas at intervals of 3 cm to
isolate sections. Thereafter the entire length of the vas
deferens was excised and transverse serial sections were
stained with HE stain and examined under light microscope. The vas deferens on the other side was
excised without placing knots and was frozen. Serial
sections were taken to determine the diameter of the vas
lumen along the length of the vas deferens.
Group II consisted of two adult rhesus monkeys,
also proven fertile and with bodyweights above 7 kg.
Into each vas deferens 120 µL of RISUG was injected.
Six weeks post-injection semen samples were collected
twice at intervals of 1 week by electro-ejaculation
adopting penile stimulation. At 8 weeks post-injection the
entire vas deferens was surgically exposed and knots placed
around the vas deferens at intervals of 3 cm. The vas
deferens was excised and transverse serial sections were
stained with HE stain and examined under light microscope.
The polyelectrolyte drug RISUG is in the form of a
sterile viscous liquid when in the delivery syringe, which
has a special design to generate high-injection pressure.
As mentioned, the styrene maleic anhydride component
has a covalent bond linkage with the dimethyl sulfoxide.
Molecular weight is high, typically of the order of 70 000
and hence the viscosity is high. To inject the drug by
means of the blade of a sharp forceps a puncture is made
in the midline of the scrotum midway between the
peno-scrotal junction and the testicular pole. First, the left vas
is delivered through the puncture hole. It is very
important to avoid damage to the vas deferens blood vessels
and nerves because damage alters peristalsis and
subsequent distribution of the drug. A 23-gauge needle is used
for injection in the volunteer men as the optimum choice
between flow of the viscous drug and minimal damage
to the vas vessels and nerves. For monkeys, because
the size of the vas is smaller, the injection site is often
chosen more distal to the epididymal end of the vas above
the external inguinal ring. All injections are delivered with
the needle pointing distally and maintaining a
compression of the proximal vas deferens so that there is no
backflow of the drug towards the epididymis. Also it is
important to maintain the compression on the vas for a
period of 2 min after the injection and withdrawal of the
needle to ensure that some drug-intraluminal vas fluid
interaction takes place and the drug becomes a gel with
no backward flow.
3 Results
During pretreatment, the sperm typically had an
anterior tapering head, which in HE staining had a light
staining anterior part representing the acrosomal cap. A
well-marked dark-stained region in the posterior twothirds of the head existed. The tails were long with
gradual curvature changes. The anterior twothirds of
the tail had a curve with the radius of curvature being
onethird or more of the length of the tail. The
morphology changed after exposure to RISUG.
3.1 Human subject Group I
Fifty percent of 3-h post-treatment sample sperm
had an enlarged head with the anterior region of the head
broader than the posterior region. The size of the
light-staining zone reduced relative to the dark-staining region.
Figure 1 is a SEM of the semen of a subject taken 3 h
after the injection showing grades of affected sperms
and polymer. Results are summarized in Tables 1 and 2.
In Figure 1, sperm A is near normal, sperm B has a
minimally affected head and sperm C has a markedly altered
head structure. All sperms have near normal tails. TEM
of semen samples from this group show in 50% of sperms only a patchy loss of plasma membrane with
intact acrosomes. Twenty percent of sperms were
significantly affected by the RISUG. Heads were enlarged
and deformed with loss of the plasma membrane and the
acrosome. Chromatin decondensation was present but
chromatin was not quite in the granular form.
3.2 Human subject Group II
Morphological examination of sperms showed that the
majority had undergone acrosome reaction. TEM shows
an effect on acrosome, plasma membrane and the nucleus
(Figure 2). Many sperms had a marked loss of acrosome
and chromatin in granular form. A detailed acrosome
reaction study on four subjects by triple stain technique
showed that 65% of sperms had undergone acrosome reaction [9]. The ratio between dead acrosome-reacted
sperm to live acrosome-reacted sperm varied widely from
subject to subject. Generally, there are more dead sperms
seen amongst the acrosome reacted sperm than the acrosome unreacted sperms in the same semen sample.
The head may be quite deformed or even disrupted. Tails
seem to be more resistant to RISUG. Approximately
80% of the sperms did have the tail but the
electron-micrographic images showed that the tails too were
affected (Figure 3). Mitochondrial gyri were disturbed
and the transverse view of the tail exhibited changes
in the microtubular structure. Headtail detachment
was not prevalent as noted in light microscopic and
SEM examinations.
3.3 Human subject Group III
Within 6 weeks of the injection no morphologically
intact sperms were present in the ejaculate. Structures
that may be recognized as breakdown products of sperms
were seen. In all these structures no long tail was present.
A few sperms with swollen and partially ruptured heads
with what appeared to be stubs of the tail were present.
Significantly, instead of headtail detachment there was
a shortening of the tail. The portion of the tail which
was lost was not seen as a separate piece.
3.4 Monkey Group I
The sperm morphology seen in the proximal and
distal segments of the vas deferens was the same.
3.5 Monkey Group II
In the semen 6 weeks post-injection there was
evidence of marked sperm destruction without a total vas
deferens lumen obstruction. That is, the semen had only
sperm breakdown products. The important observation
is that the sperms in the proximal segment of the vas
deferens retain the tails. Sperms in the distal segment
generally appeared to have very short tails. These forms
were not mature sperm precursors. Furthermore, distally,
structures like spherically deformed heads were seen
without any remnants of the tail.
4 Discussion
Observations on Group I humans correlates well with
biophysical study results that it takes approximately 72 h
for full hydrolytic conversion and swelling of RISUG to
occur. In the short period of 3-h post-injection the
reactions are incomplete and invaginations into mucosal folds
are not sufficient to develop a retentive action to oppose
evacuation caused by vas deferens peristalsis. The
ejaculation process is known to enhance peristalsis and
segmental contractions in the vas deferens. Hence the 3-h
post-injection semen sample contains small aggregates
of precipitated RISUG evacuated by the peristaltic action.
Moreover the drug spread from scrotal vas deferens
injection site by peristalsis is only partial and distal
segments are virtually devoid of RISUG. In the short period
of exposure of spermatozoa to RISUG and spermatozoa
in the distal segments of the vas not being exposed to
RISUG varied degrees of effects on sperm occurs,
giving normal and partially affected spermatozoa. All of the
above mentioned changes characterize the effects of
short-term exposure to RISUG.
In previous studies on monkey, by inserting micro
pH probes into the lumen of the vas deferens it has been
observed that the pH lowering effect after RISUG
injection gradually develops over a week. Therefore, for the
3-h post-injection sample the effects may be attributed
more to the electrical charge of the RISUG.
The vas deferens lumen diameter is approximately
0.6 mm with considerable space occupied by RISUG.
Sperms move in close proximity to RISUG with polymer charge_sperm charge interaction. Concomitant with
transmembrane ion transport variation, water transport
is also affected, leading to edema and acrosomal rupture.
Acrosomal compounds, acrosin and hyaluronidase, are
liberated as can be extrapolated from observations on
in vitro exposure of sperms to RISUG done in our laboratory.
These enzymes are autolytic agents and further act on
the sperm thus changing sperm morphology.
RISUG charge also affects sperm chromatin, which
normally has well compacted DNA. Normal sperms have
protamines as alpha helices. Lying in the major grooves
of DNA, protamines neutralize the negatively charged
phosphate backbone and enable DNA duplexes to pack
tightly together. The charge action of SMA probably
inhibits the negative charge neutralization leading to
unpacking of the DNA, chromatin decondensation and
swelling of the sperm head. Chromatin decondensation
is known to be associated with subfertility and infertility
[10]. The contraceptive action of RISUG administration
is, in part, accounted for by this factor.
The outcome of Group II men differs from the
earlier group even though both have low intra-vas deferens
RISUG content. In Group II, by vas peristalsis, the drug
spreads almost to the entire length of the vas deferens.
Also the polymer undergoes complete hydrolytic action
with greater manifestation of electrical charge and pH
lowering. Effects are significant on account of longer
spermdrug interaction with a more active form of the
drug. There are fewer headtail detachments as compared to that observed on exposure to primary amines
such as ethylamine and anionic detergents like sodium
dodecyl sulphate [11]. However, there is greater effect
on the acrosome and nucleus. The difference indicates
that the mechanism of action of RISUG is different to
that of primary amines, detergents and sulphydryl reagents. This finding also explains why primary amines,
detergents and sulphydryl agents do not serve as an
intra-vas contraceptive.
The sperm character in the Group III men has a
presentation that differs from the headtail separation
occurring under the in vitro action of agents such as
primary amines in sperms. Group III sperm appearance
can better be described as "dissolution" of the tail with
the terminal segments of the tail being more susceptible
to the dissolution effect. A possible explanation is that
the tail is more negatively charged than the head and so
plasma membrane of the tail is more resistant to charge
mediated damages than the head. But once the tail
membrane does get affected, mitochondria and
microtubule-associated protein breakdown rapidly follows. However,
the nucleus, with its large DNA content, is more
resistant to dissolution because of stabilization by nuclear
disulphide bonds (SS) and neutralization of negatively
charged phosphate backbone by the alpha helices of
protamines lying in the major grooves of DNA.
Drug action progresses with increased exposure time
and path length of spermpolymer contact. Acrosomal
structures are affected first followed by effects on the
sperm nucleus. Subsequently tail mitochondrial gyri are
disturbed and then there is dissolution of the terminal
segments of the tail. The sperm structure seen in serial
sections of the monkey vas deferens confirm that the
action on the sperm increases as the sperms travel from
the proximal to the distal segment of the vas deferens
containing the RISUG implant. These results correlate
with necroasthenoteratozoospermic changes in ejaculated
sperm several days following contraceptive drug
injection in the monkey [12].
Overall results presented here show a timed set of
actions on sperms mediated by a bioactive compound.
Some of the effects such as swollen rounded sperm heads
and short tails are known to exist in disease states but
are not reported in relation to the actions of synthetic
compounds that affect sperms. The disease states which
are associated with these specific sperm abnormalities
are also linked to low fertility. Therefore, inducing these
changes is a means of contraception and this
phenomena is further demonstrated by the fertility control in the
subjects of the study. Also, the findings suggest that
sustained intra-epididymal and intra-vas low pH conditions
together with electrical charge abnormalities may be a
combination of factors that can produce sperm
abnormalities in the diseased state. Therefore, correction of
pH and electrical charge levels by intra-epidiymal and
intra-vas deferens injection of therapeutic compounds
may be a means for managing specific types of infertility.
For the purpose of looking into broader implications
of the study to male contraceptive technology it is
pertinent to consider a different field, which is sperm-ovum
interaction. There is a set of marked similarities between
the effects on the sperm following intra-vas deferens
exposure to the contraceptive polymer with the events
immediately prior and following entry of the sperm into
the ovum [13]. Changes in the sperm acrosome in the
vicinity of the ovum parallels that occurring near the
polymer. In any in vitro sperm preparation there is
clustering of sperms. A transverse section of polymer
injected in the rat and monkey vas deferens, however, does
not show any clustering. Sperm heads are seen quite
distinct in between zones of the polymer. It is as if once
a sperm enters a zone between polymer masses the
entry of other sperms is prevented somewhat akin to the
prevention of polyspermy. Within the ovum the sequence
of removal of the sperm nuclear envelope, nuclear decondensation and removal of the tail are closely matched
by the occurrences on exposure of the sperm to the
polymer within the vas deferens. These observations
suggest a possibility that some of the spermovum
interactions are charge-mediated phenomena that can be affected
even by a non-biological polyelectrolyte. As the sperm
membranes are damaged first with a consequent loss of
sperm fertility, a non-obstructive contraception can be
achieved without the risk of damaged sperms passing
into the ejaculated sperm causing teratogenic effects. This
is because before the nucleus is affected the sperms have
been rendered infertile. Non-obstructive vas contraception avoids many of the adverse effects of epididymal
and testicular pressure rise following vas blockage by
vasectomy and plugs.
Acknowledgment
Clinical procedures were conducted by Dr Gulshanjit
Singh, Head of the Department of Surgery, Deen Dayal
Updhyay Hospital, New Delhi (formerly at LNJP Hospital,
New Delhi) and Dr H. C. Das, Head of the Male Family
Planning Unit, LNJP Hospital, New Delhi. Financial grants
from the Ministry of Health and Family Welfare (FW)
are gratefully acknowledged. Basic research projects
supported by the Indian Council of Medical Research
have stimulated the research on this subject.
References
1 Guha SK. Bioengineering in Reproductive Medicine. Boca
Raton: CRC Press; 1990. p151.
2 Kretschmann H, Schlodder E, Witt HT. Net charge oscillation
and proton release during water oxidation in photosynthesis:
An electrochromic band shift study at pH 5.5_7.0. Biochim
Biophys Acta 1996; 1274: 1_8.
3 Saburova EA, Dybovskaia IuN, Sivezhelezov VS, Elfamova
LI. The electrostatic contribution to interactions of some
enzymes with polyelectrolytes. Biofizika 2005; 50: 423_33.
4 Macdonald PM, Crowell KJ, Franzin CM, Mitrakos P,
Semchyschyn DJ. Polyelectrolyte-induced domains in lipid
bilayer membranes: the deuterium NMR perspective. Biochem
Cell Biol 1998; 76: 452_64.
5 Breton S, Smith PJ, Lui B, Brown D. Acidification of the male
reproductive tract by a proton pumping (H+)-ATPase. Nat
Med 1996; 2: 470_2.
6 Lohiya NK, Manivannan B, Mishra PK, Sriram S, Bhande SS,
Panneerdoss S. Preclinical evaluation for noninvasive reversal
following long-term vas occlusion with styrene maleic
anhydride in langur monkeys. Contraception 2005; 71: 214_26.
7 Guha SK, Singh G, Srivastava A, Das HC, Bhardwaj JC, Mathur
V, et al. Two-year clinical efficacy trial with dose variations of
a vas deferens injectable contraceptive for the male.
Contraception 1998; 58: 165_74.
8 Vazquez JM, Martinez E, Roca J, Coy P, Ruiz S. Use of
triple stain technique for simultaneous assessment of vitality
and acrosomal status in boar spermatozoa. Theriogenology
1992; 38: 843_52.
9 Guha SK. inventor; Contraceptive for use by a male. USA
Patent 5488075; 1996.
10 Molina J, Castilla JA, Castaño JL, Fontes J, Mendoza N,
Martinez L. Chromatin status in human ejaculated
spermatozoa from infertile patients and relationship to seminal
parameters. Hum Reprod 2001; 16: 534_9.
11 Young RJ, Cooper GW. Dissociation of intermolecular
linkages of the sperm head and tail by primary amines, aldehydes,
sulphydryl reagents and detergents. J Reprod Fertil 1983;
69:1_10.
12 Mishra PK, Manivannan B, Pathak N, Sriram S, Bhande SS,
Panneerdoss S, et al. Status of spermatogenesis and sperm
parameters in langur monkeys following long-term vas
occlusion with styrene maleic anhydride. J Androl 2003; 24:
501_9.
13 Yanagimachi R. Male gamete contributions to the
embryo. Ann N Y Acad Sci 2005; 1061: 203_7.
|